VEGFA and hepatocellular carcinoma: In HCC patients (G1), the elevated serum levels were related to the mutant allele (T) of VEGF-C936T (430.0 pg/mL), compared with the wild-type genotype (C/C) (250.5 pg/mL; P = 0.0285).